Henriette Didriksen

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial

Håvard Fretheim, Brian K. Chung, Henriette Didriksen et al. · PLoS ONE · 2020 · 70 citations · Full text

Life Sciences, Immunology, Microbiology +17

Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis

Henriette Didriksen, Øyvind Molberg, Håvard Fretheim et al. · Arthritis & Rheumatology · 2021 · 20 citations · Full text

Medicine, Cardiology, Immunology +16

Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension

Henriette Didriksen, Øyvind Molberg, Adi Mehta et al. · Frontiers in Immunology · 2022 · 13 citations · Full text

Medicine, Immunology, Pathobiology +17

Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial

Håvard Fretheim, Imon Barua, Gunnstein Bakland et al. · The Lancet Rheumatology · 2025 · 13 citations

Life Sciences, Immunology, Microbiology +16

Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial

Anna‐Maria Hoffmann‐Vold, Håvard Fretheim, Vikas K. Sarna et al. · BMJ Open · 2021 · 10 citations · Full text

Life Sciences, Immunology, Microbiology +17